Summary
Gadolinium (Gd)-DTPA enhanced magnetic resonance imaging (MRI) was performed in 15 systemic lupus. erythematosus patients with past (12) or present (3) features suggesting central nervous system (CNS) involvement. Symptomatic Gd-DTPA enhancing lesions were seen in 2 patients, and immunosuppressive treatment was associated with a rapid reversal of enhancement. The pattern of enhancement was different from that usually seen in multiple sclerosis. Gd-DTPA enhanced MRI may sometimes be useful in demonstrating the activity of CNS lupus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aisen AM, Gabrielson TO, McCune WJ (1985) MR imaging of systemic lupus erythematosus involving the brain. Am J Radiol 144:1027–1031
Bonfa E, Golombek SJ, Kaufman LD, Skelly S, Weissbach H, Brot N, Elkon KB (1987) Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 317:265–271
Boumpas DT, Patronas NJ, Dalakas MC, Hakim CA, Klippel JH, Balow JE (1990) Acute transverse myelitis in systemic lupus erythematosus: magnetic resonance imaging and review of the literature. J Rheumatol 17:89–92
Crocker EE, Zimmerman RA, Phelps ME, Kuhl DE (1976) The effect of steroids on the extravascular distribution of radiographic contrast material and technetium pertechnate in brain tumours as determined by computed tomography. Radiology 119:471–474
Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombocytopenic purpura. Ann Neurol 23:380–384
Ellis SG, Verity MA (1979) Central nervous system involvement in systemic lupus erythematosus: a review of neuropathological findings in 57 cases. Semin Arthritis Rheum 8:212–221
Harris EN, Hughes GRV (1985) Cerebral disease in systemic lupus erythematosus. Semin Immunopathol 8:251–266
Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV (1984) Cerebral infarction in systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Exp Rheumatol 2:47–51
Imakita S, Nishimura T, Naito H, Yamada K, Takamiya M, Sakashita Y, Minamikawa J, Kikuchi H, Terada T (1987) Magnetic resonance imaging of human cerebral infarction: enhancement with Gd-DTPA. Neuroradiology 29:422–429
Johnson RT, Richardson EP (1968) The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 47:337–369
Larsson EM, Holtas S, Nilsson O (1989) Gd-DTPA-enhanced MR of suspected spinal multiple sclerosis. Am J Neuroradiol 10:1071–1076
Long AA, Denburg SD, Carbotte RM, Singal DP, Denburg JA (1990) Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis 49:249–253
Lyons BE, Enzmann DR, Britt RH, O'Bana WG, Platone RC, Yeager AS (1982) Short term high dose corticosteroids in computed tomographic staging of experimental brain abscess. Neuroradiology 23:279–284
Matthews WB (1991) McAlpine's multiple sclerosis. Churchill Livingstone, Edinburgh
Mikhael A (1990) Serial-enhanced MR of the spinal cord and the evolution of multiple sclerosis plaques. In: Proceedings of the SMRM 9th Annual Meeting, vol 1. Society of Magnetic Resonance in Medicine, Berkeley, Calif, p 148
Miller DH, Ormerod IEC, Gibson A, du Boulay EPGH, Rudge P, McDonald WI (1987) MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 29:226–231
Miller DH, Rudge P, Johnson G, Kendall BE, MacManus DG, Moseley IF, Barnes D, McDonald WI (1988) Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111:927–939
Miller DH, Thompson AJ, Morrissey SP, MacManus DG, Moore SG, Kendall BE, Moseley IF, McDonald WI (in press) High dose steroids in multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect. J Neurol Neurosurg Psychiatry
Schott AM, Colson F, Tebib J, Noel E, Bouvier M (1990) Magnetic resonance imaging and lupus erythematosus of the nervous system. Rev Rhum Mal Osteoartic 57:785–790
Tan EM, Cohen ES, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1272
Vermess M, Bernstein RM, Bydder GM, Steiner RE, Young IR, Hughes GRV (1983) Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus. J Comput Assist Tomogr 7:461–467
Winfield JB, Shaw M, Silverman LM, Eisenberg RA, Wilson HA, Koffler D (1983) Intrathecal IgG synthesis and blood-brain-barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction. Am J Med 74:837–844
Zvaifler NJ, Bluestein HG (1982) The pathogenesis of central nervous system manifestation of systemic lupus erythematosus. Arthritis Rheum 25:862–866
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, D.H., Buchanan, N., Barker, G. et al. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus. J Neurol 239, 460–464 (1992). https://doi.org/10.1007/BF00856812
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00856812